The threat of
anthrax as a biological weapon has become a real concern for
everyone. Anthrax is a disease caused not by a virus, but rather
by bacteria. There aren't any known cases of anthrax
passing from one person to another, so it is considered to be
noncontagious. It is still a large threat, however, because if it
isn't recognized and treated quickly enough it can be deadly. Bacillus
anthracis is the bacterium that causes the disease anthrax. It
has historically affected herbivores like cattle, sheep or other
grazing herds, but has also been a threat to humans who work with
these animals and their by-products.
While in the ground or on a surface, anthrax spores are relatively
harmless, but once they come into contact with the right
environment they begin to germinate. They need an environment that
is rich in amino acids, nucleosides and glucose -- like those
elements found in blood and other tissues in humans or animals.
Once there, a series of changes takes place that can make these
bacteria deadly to its host.
Anthrax is found all over the world. It
contaminates the ground when an affected animal dies. It spreads
when grazing animals pick it up from contaminated dirt or through
contaminated food sources such as bone meal that may have been made
from contaminated carcasses. There appears to be an increase in the
cases of anthrax among grazing animals during droughts, when they
tend to graze closer to the ground and consume more dirt with the
grass.
Anthrax may also spread when
carnivorous animals, such as vultures or even insects, feed on
affected herbivores. The bacteria are then transferred to other
areas by the host and contaminate the ground when that animal dies.
As the animal decays, the bacteria are exposed to oxygen and turn
back into the spores that contaminate the soil. The anthrax spores
have a very tough outer casing and can remain viable in the ground
for decades.
Anthrax cycle
Many diagnostic laboratories around
the world have anthrax samples for use in research and for the
identification of anthrax. Anthrax can be grown in laboratories from
these existing spores. In the wrong hands, these spores can be
grown, dried and milled for use in biological weapons.
Inhalation into the lungs
(inhalation anthrax) - The spores can be inhaled in contaminated
soil or other particles containing the spores. The spores have
no smell, taste or color, so a person would not notice anything
had happened unless the spores had been mixed into a substance
that could be readily seen, smelled or tasted. In order to enter
the lungs, where they can germinate, the spores have to be very
small -- from 1 to 5 microns (millionths of a meter). According
to an anthrax report published by the American Medical
Association, at least 2,500 spores have to be inhaled to cause
an infection.
Inhaled anthrax
Entry into a cut or opening in the
skin (cutaneous or skin anthrax) - Open cuts and scrapes can
allow entry of the spores into the body to an environment in
which they can germinate. This type of anthrax may
also be spread by biting insects that have fed on infected
hosts. The head, arms and hands are most often affected. People
who handle contaminated animal products such as leather, hair
(particularly goat hair) and wool are often exposed to the
anthrax bacteria. Cutaneous anthrax accounts for about 95
percent of cases worldwide. If untreated, it has a fatality rate
of five to 20 percent. If treated with antibiotics,
it rarely leads to death.
Cutaneous anthrax
Entry through the gastrointestinal
tract (gastrointestinal anthrax) - Eating undercooked meat that
is infected with the anthrax bacteria, or drinking unchlorinated
water that harbors the spores, can introduce the bacteria into
the gastrointestinal tract. Infection can occur in either the
upper or lower GI tract. This form of anthrax is rare.
When viewed at the
cellular level, an anthrax bacterium looks like a jointed bamboo
rod. When it enters the body and finds the environment it needs, it
moves to the lymph nodes. From there it begins to multiply and
produce a toxin that attacks human cells resulting in hemorrhaging,
swelling, a drop in blood pressure and ultimately death.
Anthrax bacteria (Bacillus anthracis), stained
The way it attacks
the cells and exactly what it does was in question for many years.
Research that began in the mid 1980s has revealed some interesting
facts about the behavior of the anthrax bacterium when it finds a
host.
Researchers found
that there are three proteins that are created by the anthrax
bacteria. These proteins are harmless individually, but together can
be deadly. These proteins are referred to as:
Protective
antigen (PA)
Edema factor
(EF)
Lethal factor
(LF)
When these proteins
are released, the protective antigen binds to the cell surface and
forms a type of channel in the cell membrane that allows the edema
factor and lethal factor to enter the cell. The edema factor, when
combined with the protective antigen, forms a toxin known as the edema
toxin. The lethal factor, when combined with the protective
antigen, forms a toxin known as the lethal toxin. It is the
lethal toxin that does the most damage within the cell.
Research in 1998, by
George Vande Woude at the National Cancer Institute in Frederick,
MD, revealed clues to what the lethal toxin does to the cells. He
found that the lethal factor cuts enzymes in two -- the enzymes that
are responsible for transmitting signals within the cells. He also
identified the enzyme in question. He was studying the mitogen-activated
protein kinase (MAPK) pathway, which helps control cell
growth, embryonic development and the way oocytes (eggs) mature. He
was specifically looking for information about what the pathway
actually did in the oocyte maturation cycle, so he searched for
compounds that blocked the activity of the MAPK. A database search
lead him to the lethal factor.
It is still not
completely understood why disrupting the signal transmission within
the cell results in the symptoms anthrax generates, but research
continues. Research is also being done to find ways to alter the
protective antigen to disable its ability to allow the entry of the
lethal and edema toxins into cells.
In its bacterial state, anthrax
survives outside of a proper host environment for only about 24
hours. But inside the body, where it gets the nutrients it needs to
grow, anthrax germinates and spreads rapidly.
Inhalation
Anthrax
Inhaled anthrax typically begins showing symptoms in seven to
10 days, although it could be as early as two to three days. It can
take as long as 60 days after exposure to the anthrax spores for the
disease to surface, however, and once the germination begins, the
disease progresses very rapidly. It appears to come in two stages:
It begins with
fever, cough, headache, vomiting, chills, weakness, abdominal
pain, shortness of breath and chest pain. This first stage may
last from a few hours to a few days. Then there may be a brief
break in symptoms.
The second stage
of the disease lasts anywhere from two to four days. The
symptoms for the second stage include fever, difficulty
breathing, sweating, a bluish discoloration of the skin, shock,
and finally death.
Cutaneous
Anthrax
Cutaneous anthrax, which occurs when the anthrax spore is
deposited into a break in the skin, may occur as late as 12 days
after exposure. The germination of the bacteria results in local swelling
of the skin -- a small papule (bump) will appear. The following day
the bump will enlarge into an ulcer and begin discharging a clear
fluid. Then, a painless, depressed black scab will form that will
dry and fall off within one to two weeks. Treatment with antibiotics
may not change the appearance or formation of the bumps, but they
decrease the chances that the disease will become systemic.
Gastrointestinal
Anthrax The gastrointestinal form of anthrax, which occurs from
eating or drinking infected meats or water, brings about symptoms
that include nausea, vomiting blood, abdominal pain, bloody
diarrhea, and weakness. Death occurs in 25 to 60 percent of these
cases.
According to an article in the Journal of the American Medical
Association, a blood sample is taken from the patient and cultured
for six to 24 hours. At this point, a "Gram stain" can
be done. The Gram stain highlights the bacteria.
Anthrax bacteria in Gram stain
The Gram stain
takes about 10 to 15 minutes and can identify whether the bacteria
come from the anthrax category. At that point, biochemical testing
can be done to find the specific anthrax bacteria, which takes
another 12 to 24 hours. Usually, the specimens have to be sent to
national reference laboratories for comparison with stock anthrax
samples.
Treatment
Anthrax is treated with the antibiotics penicillin, ciprofloxacin
or doxycylcine. The antibiotic most often used is ciprofloxacin,
partly because of rumors that the Soviet Union had developed a
penicillin-resistant form of anthrax for use in biological
warfare. It is also specifically recommended by the U.S. Food and
Drug Administration (FDA) for use in treating anthrax.
Treatment of
inhaled anthrax has to start very early in the progression of
symptoms. If treatment is begun after the symptoms have progressed
too far, then the bacteria may be killed but the toxins remain in
the body.
Inhalation into the lungs
(inhalation anthrax) - The spores can be inhaled in contaminated
soil or other particles containing the spores. The spores have
no smell, taste or color, so a person would not notice anything
had happened unless the spores had been mixed into a substance
that could be readily seen, smelled or tasted. In order to enter
the lungs, where they can germinate, the spores have to be very
small -- from 1 to 5 microns (millionths of a meter). According
to an anthrax report published by the American Medical
Association, at least 2,500 spores have to be inhaled to cause
an infection.
Inhaled anthrax
Entry into a cut or opening in the
skin (cutaneous or skin anthrax) - Open cuts and scrapes can
allow entry of the spores into the body to an environment in
which they can germinate. This type of anthrax may
also be spread by biting insects that have fed on infected
hosts. The head, arms and hands are most often affected. People
who handle contaminated animal products such as leather, hair
(particularly goat hair) and wool are often exposed to the
anthrax bacteria. Cutaneous anthrax accounts for about 95
percent of cases worldwide. If untreated, it has a fatality rate
of five to 20 percent. If treated with antibiotics,
it rarely leads to death.
Cutaneous anthrax
Entry through the gastrointestinal
tract (gastrointestinal anthrax) - Eating undercooked meat that
is infected with the anthrax bacteria, or drinking unchlorinated
water that harbors the spores, can introduce the bacteria into
the gastrointestinal tract. Infection can occur in either the
upper or lower GI tract. This form of anthrax is rare.
When viewed at the
cellular level, an anthrax bacterium looks like a jointed bamboo
rod. When it enters the body and finds the environment it needs, it
moves to the lymph nodes. From there it begins to multiply and
produce a toxin that attacks human cells resulting in hemorrhaging,
swelling, a drop in blood pressure and ultimately death.
Anthrax bacteria (Bacillus anthracis), stained
The way it attacks
the cells and exactly what it does was in question for many years.
Research that began in the mid 1980s has revealed some interesting
facts about the behavior of the anthrax bacterium when it finds a
host.
Researchers found
that there are three proteins that are created by the anthrax
bacteria. These proteins are harmless individually, but together can
be deadly. These proteins are referred to as:
Protective
antigen (PA)
Edema factor
(EF)
Lethal factor
(LF)
When these proteins
are released, the protective antigen binds to the cell surface and
forms a type of channel in the cell membrane that allows the edema
factor and lethal factor to enter the cell. The edema factor, when
combined with the protective antigen, forms a toxin known as the edema
toxin. The lethal factor, when combined with the protective
antigen, forms a toxin known as the lethal toxin. It is the
lethal toxin that does the most damage within the cell.
Research in 1998, by
George Vande Woude at the National Cancer Institute in Frederick,
MD, revealed clues to what the lethal toxin does to the cells. He
found that the lethal factor cuts enzymes in two -- the enzymes that
are responsible for transmitting signals within the cells. He also
identified the enzyme in question. He was studying the mitogen-activated
protein kinase (MAPK) pathway, which helps control cell